Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
Tumor cells disseminate into compartments that are poorly accessible from circulation, which necessitates high doses of systemic chemotherapy. However, the effectiveness of many drugs, such as the potent topoisomerase I poison SN-38, is hampered by poor pharmacokinetics. To deliver SN-38 to lymphoma...
Main Authors: | Abraham, Wuhbet, Zheng, Yiran, Huang, Bonnie, Bustamante Lopez, Sandra C, Irvine, Darrell J, Luo, Samantha |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
American Association for the Advancement of Science (AAAS)
2017
|
Online Access: | http://hdl.handle.net/1721.1/108108 https://orcid.org/0000-0003-0817-0525 |
Similar Items
-
Lymphocyte-mediated drug nanoparticle delivery to disseminated lymphoma tumors in vivo
by: Huang, Bonnie
Published: (2013) -
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
by: Zheng, Yiran, et al.
Published: (2014) -
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy
by: Mashelkar, Raghunath Anant, et al.
Published: (2010) -
Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells
by: Zheng, Yiran, et al.
Published: (2020) -
Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
by: Zhang, Yuan, et al.
Published: (2018)